Novel modes of antifungal drug administration

Expert Opinion on Investigational Drugs

Volumn 13, Issue 8, 2004, Pages 903-932

  Arthur, Rebekah R ^a   Drew, Richard H ^a,b   Perfect, John R ^b  

^a Campbell University   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aerosol; Antifungals; Drug administration; Endobronchial; Intrathecal; Irrigation; Nasal spray; Ophthalmic; Percutaneous; Peritoneal

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ATROPINE; BECLOMETASONE; BICARBONATE; BONE CEMENT; CROMOGLYCATE DISODIUM; FLUCONAZOLE; FLUCYTOSINE; GENTAMICIN; HYDROCORTISONE; ITRACONAZOLE; KETOCONAZOLE; METHYLENE BLUE; MICONAZOLE; NATAMYCIN; NYSTATIN; POSACONAZOLE; PREDNISONE; PROCATEROL; SALMETEROL; THEOPHYLLINE;

ANTERIOR EYE CHAMBER; ARACHNOIDITIS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BACKACHE; BLADDER IRRIGATION; BRAIN HEMORRHAGE; BRONCHOPULMONARY ASPERGILLOMA; BRONCHOSPASM; CANDIDIASIS; CLINICAL TRIAL; COUGHING; DRUG ADMINISTRATION; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; DYSPNEA; EPISTAXIS; FECES INCONTINENCE; FEMALE; FUNGAL MENINGITIS; HEADACHE; HUMAN; INTRACAMERAL DRUG ADMINISTRATION; INTRACISTERNAL DRUG ADMINISTRATION; INTRASPINAL DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; LEG PAIN; MALE; MUSCLE WEAKNESS; MYCOSIS; NAUSEA; PARAPLEGIA; PARESTHESIA; PERCUTANEOUS DRUG ADMINISTRATION; REVIEW; SPINAL CORD LESION; SPUTUM; TASTE DISORDER; URINE INCONTINENCE; VOMITING; WHEEZING;

ANTIFUNGAL AGENTS; DRUG ADMINISTRATION ROUTES; HUMANS;

EID: 4344693285     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.13.8.903     Document Type: Review

References (235)

1. LETSCHER-BRU V, HERBRECHT R: Caspofungin: the first representative of a new antifungal class. J. Antimicrob. Chemother. (2003) 51:513-521.
2. SOBEL J: Practice guidelines for the treatment of fungal infections. Clin. Infect. Dis. (2000) 30:652
3. KAO AS, BRANDT ME, PRUITT WR et al.: The epidemiology of candidemia in two United States cities: Results of a population-based active surveillance. Clin. Infect. Dis. (1999) 29:1164-1170.
4. STEVENS D, KAN VL, JUDSON MA et al.: Practice guidelines for diseases caused by Apergillus. Clin. Infect. Dis. (2000) 30:696-709.
5. GOLDMAN HJ, LITTMAN ML, OPPENHEIMER GD, GLICKMAN SI: Monilial cystitis - effective treatment with instillations of amphotericin B. JAMA (1960) 174(4):359-362.
6. EWING A: Amphotericin B lozenges in the treatment of oral thrush. Practitioner (1967) 199:62-67.
7. SHEPPARD D, LAMPIRIS HW: Antifungal agents. In: Basic and Clinical Pharmacology (7). Katzung BG (Ed.), Appleton and Lange, New York, USA (1998):780-787.
8. SEHGAL VN, KHANDPUR S: Antifungal agents: Unapproved uses, dosages, or indications. Clin. Dermatol. (2002) 20:481-489.
9. GOODMAN J, KOENIG M: Amphotericin B-specifics of administration. Modern Treatment (1970) 7(3):581-595.
10. WINN WA: The treatment of coccidioidal meningitis - the use of amphotericin B in a group of 25 patients. Calif Med. (1964) 101(2):78-89.
11. SANFORD WG, RASCH JR, STONEHELL RB: A therapeutic dilemma: the treatment of disseminated coccidioidomycosis with amphotericin B. Ann. Intern. Med. (1962) 56(4):553-563.
12. BUTLER WT, ALLING DW, SPICKARD A, UTZ J: Diagnostic and prognostic value of clinical and laboratory findings in cryptococcal meningitis. N. Engl J. Med. (1964) 270(2):59-66.
13. JOHNS KJ, O'DAY D: Pharmacologic management of keratomycoses. Surv. Ophthalmol. (1988) 33(3):178-188.
14. DERESINSKI SC, LILLY RB, LEVINE HB, GALGIANI J, STEVENS D: Treatment of fungal meningitis with miconazole. Arch. Intern. Med. (1977) 137:1180-1185.
15. CARVER PL: Invasive fungal infections. In: Pharmacotherapy: a Pathophysiologic Approach (4). J Dipiro (Ed.), McGraw-Hill, New York, USA (1999):1839-1866.
16. RIDDELL RW. Fungous diseases of Britain. Br. Med. J. (1956) 2:783-786.
17. KILBURN K: The innocuousness and possible therapeutic use of aerosol amphotericin B. Am. Rev.,Respir. Dis. (1959) 80:441-442.
18. OEHLING A, GIRON M, SUBIRA M: Aerosol chemotherapy in bronchopulmonary candidiasis. Respiration (1975) 32(2):179-184.
19. McKENDRICK GDW, MEDLOCK JM: Pulmonary moniliasis treated with nystatin aerosol. Lancet (1958) 1:621-622.
20. GERO S, SZEKELY J: Pulmonary moniliasis treated with nystatin aerosol. Lancet (1958) 1:1229-1230.
21. KLEPSER M: Amphotericin B in lung transplant recipients. Ann. Pharmacother. (2002) 36(1):167-169.
22. CONNEALLY E, CAFFERKEY M, DALY P, KEANE C, McCANN S: Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. Bone Marrow Transplant. (1990) 5(6):403-406.
23. BEHRE G, SCHWARTZ S, LENZ K et al.: Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients. Ann. Hematol. (1995) 71(6):287-291.
24. DE LAURENZI A, MATTEOCCI A, LANTI A, PESCADOR L, BLANDINO F, PAPETTI C: Amphotericin B prophylaxis against invasive fungal infections in neutropenic patients: a single center experience from 1980 to 1995. Infection (1996) 24(5):361-366.
25. REICHENSPURNER H, GAMBERG P, NITSCHKE M et al.: Significant reduction in the number of fungal infections after lung-, heart-lung and heart transplantation using aerosolized amphotericin B prophylaxis. Transplant. Proc. (1997) 29(1-2):627-628.
26. CALVO V, BORRO J, MORALES P et al.: Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group. Chest (1999) 115(5):1301-1304.
27. SCHWARTZ S, BEHRE G, HEINEMANN V et al.: Aerosolized amphotericin B inhalations as prophylaxis of invasive Apergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial. Blood. (1999) 93(11):3654-3661.
28. MONFORTE V, ROMAN A, GAVALDA J et al.: Nebulized amphtericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors. J. Heart Lung Transplant (2001) 20(12):1274-1281.
29. HERTENSTEIN B, KERN W, SCHMEISER T et al.: Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia. Ann. Hematol. (1994) 68(1):21-26.
30. PURCELL I, CORRIS P: Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema. Thorax (1995) 50(12):1321-1323.
31. KANJ S, WELTY-WOLF K, MADDEN J et al.: Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature. Medicine (1996) 75(3):142-156.
32. DALCONTE I, RIVA G, OBERT R et al.: Tracheobronchial aspergillosis in a patient with AIDS treated with aerosolized amphotericin B combined with itraconazole. Mycoses (1996) 39(9-10):371-374.
33. BIRSAN T, TAGHAVI S, KLEPETKO W: Treatment of Aspergillus-related ulcerative tracheobronchitis in lung transplant recipients. J. Heart Lung Transplant (1998) 17(4):437-438.
34. PALMER S, PERFECT J, HOWELL D et al.: Candidal anastomotic infection in lung transplant recipients: successful treatment with a combination of systemic and inhaled antifungal agents. J. Heart Lung Transplant. (1998) 17(10):1029-1033.
35. PALMER S, DREW R, WHITEHOUSE J et al.: Safety of aerosolized amphotericin B lipid complex in lung transplant recipients. Transplantation (2001) 72(3):545-548.
36. RUFFINI E, BALDI S, RAPELLINO M et al.: Fungal infections in lung transplantation. Incidence, risk factors and prognostic significance. Sarcoidosis. Vasc. Diffuse Lung Dis. (2001) 18(2):181-190.
37. CASEY P, GARRETT J, EATON T: Allergic bronchopulmonary aspergillosis in a lung transplant patient successfully treated with nebulized amphotericin. J. Heart Lung Transplant. (2002) 21(11):1237-1241.
38. SUZUKI K, IWATA S, IWATA H: Allergic bronchopulmonary aspergillosis in a 9-year-old boy. Eur. J Pediatr (2002) 161(7):408-409.
39. CHAKRAVARTY SC: Bronchopulmonary candidiasis: clinical aspect. Dis. Chest (1967) 51(6):608-613.
40. DUBOIS J, BARTTER T, GRYN J, PRATTER M: The physiologic effects of inhaled amphotericin B. Chest. (1995) 108(3):750-753.
41. GRYN J, GOLDBERG J, JOHNSON E, SIEGEL J, INZERILLO J: The toxicity of daily inhaled amphotericin B. Am. J. Clin. Oncol. (1993) 16(1):43-46.
42. ERJAVEC Z, WOOLTHUIS G, VRIES-HOSPERS H et al.: Tolerance and efficacy of Amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients. Eur. J. Clin. Microbiol. (1997) 16(5):364-368.
43. ROTH C, GEBHART J, JUST-NUBLING G, EISENHART-ROTHE B, BEINHAUER-REEB I: Characterization of amphotericin B aerosols for inhalation treatment of pulmonary aspergillosis. Infection (1996) 24(5):354-360.
44. DREW R, DAVIS RD, BENJAMIN DK, PERFECT J: Comparative safety of aerosolized amphotericin B lipid complex (Abelcet) and amphotericin B deoxycholate (Fungizone) as antifungal prophylaxis in lung transplant recipients: A randomized, double-blind study. 13th Focus on Fungal Infections. Maui, Hawaii (2003)
45. MEUNIER-CARPENTIER. F, SNOECK R, GERAIN J, MULLER C, KLASTERSKY J: Amphotericin B nasal spray as prophylaxis against aspergillosis in patients with neutropenia. N. Engl. J. Med. (1984) 311(16):1056
46. JEFFERY G, BEARD M, IKRAM R et al.: Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. Am. J. Med. (1991) 90(6):685-692.
47. TODESCHINI G, MURARI C, BONESI R et al.: Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies. Eur. J. Clin. Microbiol. (1993) 12(8):614-618.
48. JORGENSEN C, DR, FUS F et al.: Failure of amphotericin B spray to prevent aspergillosis in granulocytopenic patients. Nouv. Rev. Fr. Hematol. (1989) 31(5):327-328.
49. HSU C, CHANG R. Two-day continuous bladder irrigation with amphotericin B. Clin. Infect. Dis. (1995) 20(6):1570-1571.
50. BLUM JA: Acute monilial pyohydronephrosis: Report of a case successfully treated with amphotericin B continuous renal pelvis irrigation. J. Urol. (1966) 96:614-618.
51. CUETARA M, MALLO N, DALET F: Amphotericin B lavage in the treatment of candidial cystitis. Br. J. Urol, (1972) 44(4):475-480.
52. WISE GJ, WAINSTEIN S, GOLDBERG P, KOZINN PJ: Candidal cystitis. Management by continuous bladder irrigation with amphotericin B. JAMA (1973) 224(12):1636-1637.
53. ROHNER TJ, TULISZEWSKI R: Fungal cystitis: awareness, diagnosis and treatment. J. Urol. (1980) 124(1):142-144.
54. BAETZ-GREENWALT B, DEBAZ B, KUMAR M: Bladder fungus ball: a reversible cause of neonatal obstructive uropathy. Pediatrics (1988) 81(6):826-829.
55. WISE GJ, KOZINN PJ, GOLDBERG P: Amphotericin B as a urologic irrigant in the management of noninvasive candiduria. J. Urol. (1982) 128(1):82-84.
56. HSU C, UKLEJA B: Clearance of Candida colonizing the urinary bladder by a two-day amphotericin B irrigation. Infection (1990) 18(5):280-282.
57. JACOBS L, SKIDMORE E, CARDOSO L, ZIV F: Bladder irrigation with amphotericin B for treatment of fungal urinary tract infections. Clin. Infect. Dis. (1994) 18(3):313-318.
58. FAN-HAVARD P, O'DONOVAN C, SMITH S, OH J, BAMBERGER M, ENG R.: Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria. Clin. Infect. Dis. (1995) 21(4):960-965.
59. LEU H, HUANG C: Clearance of funguria with short-course antifungal regimens: a prospective, randomized, controlled study. Clin. Infect. Dis. (1995) 20(5):1152-1157.
60. JACOBS L, SKIDMORE E, FREEMAN K, LIPSCHULTZ D, FOX N: Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. Clin. Infect. Dis. (1996) 22(1):30-35.
61. KAUFFMAN C, VAZQUEZ J, SOBEL J et al.: Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin. Infect. Dis. (2000) 30(1):14-18.
62. TRINH T, SIMONIAN J, VIGIL S, CHIN D, BIDAIR M: Continuous versus intermittent bladder irrigation of amphotericin B for the treatment of candiduria. J. Urol, (1995) 154(6):2032-2034.
63. FONG I: The value of a single amphotericin B bladder washout in candiduria. J. Antimicrob. Chemotber. (1995) 36(6):1067-1071.
64. GNAU T: Ampbotericin B dosage for bladder irrigation. Am. J. Hosp. Pharm. (1992) 49(11):2705-2706.
65. NESBIT S, KATZ L, McCLAIN B, MURPHY D: Comparison of two concentrations of amphotericin B bladder irrigation in the treatment of funguria in patients with indwelling urinary catheters. Am. J. Health. Syst. Pharm. (1999) 56(9):872-875.
66. JACOBS L: Fungal urinary tract infections in the elderly: treatment guidelines. Drugs Aging (1996) 8(2):89-96.
67. WISE GJ, GOLDMAN WM, GOLDBERG PE, ROTHENBERG RG: Miconazole: a cost-effective antifungal genitourinary irrigant. J. Urol. (1987) 138(6):1413-1415.
68. PAPPAS PG, REX J, SOBEL J et al.: Practice guidelines for the treatment of candidasis. Clin. Infect. Dis. (2004) 38:161-189.
69. KENNELLY BM: Candida albicans cystitis cured by nystatin bladder instillations. S. Afr. Med. J. (1965) 39:414-417.
70. AKTUG T, OLGUNER M, AKGUR FM, ALDIRMAZ C, HOSGOR M, YULUG N: A new ancient irrigation therapy for childhood renal candidiasis. Int. Urol. Nephrol. (1998) 30(2):127-132.
71. BARTONE F, HURWITZ R, ROJAS E, STEINBERG E, FRANCESCHINI R: The role of percutaneous nephrostomy in the management of obstructing candidiasis of the urinary tract in infants. J. Urol. (1988) 140(2):338-341.
72. ORTIZ O, LEE W. Percutaneous nephrostomy in the management of renal candidiasis. Arch. Surg. (1989) 124(6):739-740.
73. MAZER J, BARTONE F: Percutaneous antegrade diagnosis and management of candidiasis of the upper urinary tract. Urol. Clin. North Am. (1982) 9(1):157-164.
74. HILL J: Candidiasis of the urinary tract. Proc. R. Soc. Med. (1974) 67(11):1155-1156.
75. SCHMITT G, HSU A: Renal fungus balls: diagnosis by ultrasound and percutaneous antegrade pyelography and brush biopsy in a premature infant. J. Ultrasound Med. (1985) 4(3):155-156.
76. KELLER M, SELLERS BJ, MELISH M, KAPLAN G, MILLER K, MENDOZA S: Systemic candidiasis in infants: a case presentation and literature review. Am. J Dis. Child. (1977) 131(11):1260-1263.
77. BABUT J, COEURDACIER P, BAWAB F, TREGUIER C, FREMOND B: Urinary fungal bezoars in children-report of two cases. Eur. J. Pediatr. Surg. (1995) 5(4):248-252.
78. ROBINSON P, POCOCK R, FRANK J: The management of obstructive renal candidiasis in the neonate. Br. J. Urol. (1987) 59(5):380-382.
79. ARAGONA F, PASSERINI GG, PAVANELLO L, PERALE R, RIZZONI G, PAGANO F: Upper urinary tract obstruction in children caused by Candida fungus balls. Eur. Urol. (1985) 11(3):188-191.
80. WALZER Y, BEAR R: Ureteral obstruction of renal transplant due to ureteral candidiasis. Urology (1983) 21(3):295-297.
81. OLIVER S, WALKER R, WOODS D: Fluconazole infused via a nephrostomy tube: a novel and effective route of delivery. J. Clin. Pharm. Ther. (1995) 20(6):317-318.
82. CLARK M, GAUNT T, CZACHOR J: The use of fluconazole as a local irrigant for nephrostomy tubes. Mil. Med. (1999) 164(3):239-241.
83. CHUNG B, CHANG S, KIM S, CHOI H: Successfully treated renal fungal ball with continuous irrigation of fluconazole. J. Urol. (2001) 166(5):1835-1836.
84. SIMSEK U, AKINCI H, OKTAY B, KAVRAMA I, OZYURT M: Treatment of catheter-associated Candiduria with fluconazole irrigation. Br. J. Urol. (1995) 75(1):75-77.
85. RICCHETTI A, LANDIS B, MAFFIOLI A, GIGER R, ZENG C, LACROIX J: Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J. Laryngol. Otol. (2002) 116(4):261-263.
86. WADA M, BABA H, IMURA S: Prosthetic knee Candida parapsilosis infection. J. Arthroplasty (1998) 13(4):479-482.
87. IKEMOTO H: Medical treatment of pulmonary aspergilloma. Intern. Med. (2000) 39(3):191-192.
88. GIRON JM, POEY CG, FAJADET PP et al.: Inoperable pulmonary aspergilloma: Percutaneous CT-guided injection with glycerin and amphotericin B paste in 15 cases. Radiology (1993) 188:825-827.
89. MUNK PL, VELLET AD, RANKIN RN, MULLER NL, AHMAD D: Intracavitary aspergilloma: Transthoracic percutaneous injection of amphotericin gelatin solution. Radiology (1993) 188:821-823.
90. ASLAM PA, LARKIN J, EASTRIDGE CE, HUGHES FA: Endocavitary Infusion Through Percutaneous Endobronchial Catheter. Chest (1970) 57(1):94-96.
91. TSUSHIMA K, FUJIMOTO K, KUBO K, SEKIGUCHI M: Successful treatment of fungus ball in a patient with allergic bronchopulmonary aspergillosis: continuous percutaneous instillation of antifungal agents into the cavity. Intern. Med. (1996) 35(9):736-741.
92. KRAKOWKA P, TRACZYK K, WALCZAK J, HALWEG H, ELSNER Z, PAWLICKA L: Local treatment of aspergilloma of the lung with a paste containing nystatin or amphotericin B. Tubercle (1970) 51:184-191.
93. VELTRI A, ANSELMETTI G, BARTOLI G et al.: Percutaneous treatment with amphotericin B of mycotic lung lesions from invasive aspergillosis: results in 10 immunocompromised patients. Eur. Radiol. (2000) 10(12):1939-1944.
94. COCHRANE LJ, MORANO JU, NORMAN JR, MANSEL JK: Use of intracavitary amphotericin B in a patient with aspergilloma and recurrent hemoptysis, Am. J. Med. (1991) 90:654-656.
95. LEE KS, KIM YH, BAE WK: Percutaneous intracavitary treatment of a giant aspergilloma. AJR (1990) 154:1346
96. JACKSON M, FLOWER CDR, SHNEERSON JM: Treatment of symptomatic pulmonary aspergillomas with intracavitary instillatoin of amphotericin B through an indwelling catheter. Thorax (1993) 48:928-930.
97. KLEIN JS, FANG K, CHANG MC: Percutaneous transcatheter treatment of an intracavitary aspergilloma. Cardiovasc. Intervent. Radiol. (1993) 16:321-324.
98. SHAPIRO MJ, ALBELDA SM, MAYOCK RL, McLEAN GK: Severe hemoptysis associated with pulmonary aspergilloma: Percutaneous intracavitary treatment. Chest (1988) 94(6):1225-1231.
99. HARGIS JL, BONE RC, STEWART J, RECTOR N, HILLER FC: Intracavitary amphotericin B in the treatment of symptomatic pulmonary aspergillomas. Am. J. Med. (1980) 68:389-394.
100. STIKSA G, EKLUNDH G, RIEBE I, SIMONSSON BG: Bilateral pulmonary aspergilloma in ankylosing spondylitis treated wtih transthoracic intracavitary instillations of antifungal agents. Scan. J. Respir. Dis. (1976) 57:163-170.
101. RAMIREZ-R J: Pulmonary aspergilloma: endobronchial treatment. N. Engl. J. Med. (1964) 271(25):1281-1285.
102. BENNETT MR, WEINBAUM DL, FIEHLER PC: Chronic necrotizing pulmonary aspergillosis treated by endobronchial amphotericin B. South. Med. J (1990) 83(7):829-832.
103. YAMADA H, KOHNO S, KOGA H, MAESAKI S, KAKU M: Topical treatment of pulmonary aspergilloma by antifungals: Relationship between duration of the disease and efficacy of treatment. Chest (1993) 103:1421-1425.
104. HAMAMOTO T, WATANABE K, IKEMOTO H: Endobronchial miconazole for pulmonary aspergilloma. Ann. Intern. Med. (1983) 98(6):1030
105. GULERIA R, GUPTA D, JINDAL SK: Treatment of pulmonary aspergilloma by endoscopic intracavitary instillation of ketoconazole. Chest (1993) 103(4):1301-1302.
106. STEVENS DA, SHATSKY SA. Intrathecal amphotericin in the management of coccidioidal meningitis. Semin. Respir Infect. (2001) 16(4):263-269.
107. DRUTZ DJ: Amphotericin B in the treatment of Coccidioidomycosis. Drugs (1983) 26:337-346.
108. ANDRIOLE VT, KRAVETZ HM: The use of amphotericin B in man. JAMA (1962) 180(4):269-272.
109. WINN WA: Coccidioidomycosis and Amphotericin B. Med. Clin. North Am. (1963) 47:1131-1149.
110. GALGIANI J, AMPEL NM, CATANZARO A, JOHNSON RH, STEVENS D, WILLIAMS PL: Practice guidelines fbr the treatment of coccidioidomycosis. Clin. Infect. Dis. (2000) 30:658-661.
111. SPICKARD A, BUTLER WT, RIOLE VT, UTZ J: The improved prognosis of cryptococcal meningitis with amphotericin B therapy. Ann. Intern. Med. (1963) 58(1):66-83.
112. DRUTZ DJ, CATANZARO A: Coccidioidomycosis, part II. Am. Rev. Respir. Dis. (1978) 117:727-768.
113. BENNETT J: Amphotericin B toxicity: Review of selected aspects of pharmacology. Ann. Intern. Med. (1964) 61(2):335-339.
114. TAYLOR G, BOETTGER D, MIEDZINSKI L, TYRRELL D: Coccidioidal meningitis acquired during holidays in Arizona. Can. Med. Assoc. J. (1990) 142(12):1388-1390.
115. RAO H, MYERS G: Candida meningitis in the newborn. South. Med. J. (1979) 72(11):1468-1471.
116. BRISMAN R, REID R, HARRINGTON G: Intracranial cryptococcal granuloma-amphotericin B and surgical excision. Surg. Neurol. (1973) 1(1):43-45.
117. HALKIN H, RAVID M, ZULMAN J, REICHERT N: Cryptococcal meningitis treated with 5-fluorocytosine and amphotericin B. Isr. J. Med Sci. (1974) 10(9):1148-1152.
118. CAUDILL RG, SMITH CE, REINARZ JA: Coccidioidal meningitis: a diagnostic challenge. Am. J. Med. (1970) 49:360-365.
119. LABADIE E, HAMILTON R: Survival improvement in coccidioidal meningitis by high-dose intrathecal amphotericin B. Arch. Intern. Med (1986) 146(10):2013-2018.
120. BOUZA E, DREYER JS, HEWITT WL, MEYER RD: Coccidioidal meningitis: An analysis of thirty-one cases and review of the literature. Medicine (1981) 60(3):139-171.
121. SEABURY JH, DASCOMB HE: Experience with Amphotericin B. Ann. NY Acad Sci. (1960) 89:202-220.
122. LITTMAN ML: Cryptococcosis (Torulosis): Current concepts and therapy. Am. J. Med. (1959) 27:976-998.
123. LECLERC M, GIAMMONA S: Coccidioidal meningitis the use of amphotericin B intravenously and intrathecally by repeated lumbar punctures. West. J. Med. (1975) 122(3):251-254.
124. MISHIMA T, KOBAYASHI Y, OHKUBO M, MARUMO F, YOSHIMURA H: A case of renal transplant recipient complicated with cryptococcosis and amphotericin B induced acute tubular necrosis. Jpn. Circ. J. (1977) 41(9):1009-1013.
125. PETERSON C, JOHNSON S, KELLY J, KELLY P: Coccidiodal meningitis and pregnancy: a case report. Obstet. Gynecol. (1989) 73(5:Pt 2):t-6.
126. GLYNN K, ALAZRAKI N, WALTZ T: Coccidioidal meningitis. Intrathecal treatment with hyperbaric amphotericin B. Calif. Med. (1973) 119(3):6-9.
127. SNYDER CH, WHITE RS: Successful treatment of histoplasma meningitis with amphotericin B. J. Pediatr. (1961) 58(4):554-558.
128. LOUDON RG, LAWSON RA: Systemic blastomycosis: recurrent neurological relapse in a case treated with amphotericin B. Ann. Intern. Med. (1961) 55(1):139-147.
129. EINSTEIN HE, HOLEMAN CW, SANDIDGE LL, HOLDEN DH: Coccidioidal meningitis: The use of amphotericin B in treatment. Calif. Med. (1961) 94(6):339-343.
130. CARNEVALE N, GALGIANI J, STEVENS D, HERRICK M, LANGSTON J: Amphotericin B-induced myelopathy. Arch. Intern. Med. (1980) 140(9):1189-1192.
131. McINTYREH: Cryptococcal meningitis. A case successfully treated by cisternal administration of Amphotericin B with a review of recent literature. Bull. Los Angeles Neurol. Soc. (1967) 32(4):213-219.
132. VAN DELLEN J, BUCHANAN N: Intrathecal cryptococcal lesion of the cauda equina successfully treated with intrathecal amphotericin B: A case report. S. Afr. Med. J. (1980) 58(3):137-138.
133. KEANE J: Cisternal puncture complications. Treatment of coccidioidal meningitis with amphotericin B. Calif. Med. (1973) 119(3):10-15.
134. WITORSCH P, WILLIAMS TWJ, OMMAYA AK, UTZ JP: Intraventricular administration of amphotericin B. Use of subcutaneous reservoir in four patients with mycotic meningitis. JAMA (1965) 194(7):699-702.
135. LEPAGE E: Using a ventricular reservoir to instill amphotericin B. J.Neurosci. Nurs. (1993) 25(4):212-217.
136. BUXHOFER V, RUCKSER R, KIER P et al.: Successful treatment of invasive mould infection affecting lung and brain in an adult suffering from acute leukaemia. Eur. J. Haematol. (2001) 67(2):128-132.
137. GRAYBILL J, ELLENBOGEN C: Complications with the Ommaya reservoir in patients with granulomatous meningitis. J. Neurosurg. (1973) 38:477-480.
138. HAMILL R, ONEY LA, CRANE LR. Successful therapy for rhinocerebral mucormycosis with associated bilateral brain abscesses. Arch. Intern. Med. (1983) 143:581-583.
139. CRAVEN P, GRAYBILL J, JORGENSEN J, DISMUKES W, LEVINE B: High-dose ketoconazole for treatment of fungal infections of the central nervous system. Ann. Intern. Med. (1983) 98(2):160-167.
140. FONG K, SENEVIRATNE E, McCORMACK J: Mucor cerebral abscess associated with intravenous drug abuse. Aust. N. Z. J. Med. (1990) 20(1):74-77.
141. POLSKY B, DEPMAN MR, GOLD JWM, GALICICH JH, ARMSTRONG D: Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir. Am. J. Med, (1986) 81:24-28.
142. DAVIS S, DONOVAN W: Combined intravenous miconazole and intrathecal amphotericin B for treatment of disseminated coccidioidomycosis. Chest. (1979) 76(2):235-236.
143. SCHONHEYDER H, THESTRUP-PEDERSEN K, ESMANN V, STENDERUP A; Cryptococcal meningitis: complications due to intrathecal treatment. Scand. J. Infect. Dis. (1980) 12(2):155-157.
144. MOHSENIPOUR I, SCHIRMER M, FRANK R et al.: Local application of antimycotics in Mucormycosis cerebri: a case report. J. Neurol. Neurosurg. Psychiatry (1996) 61(5):521-522.
145. SUNG J, GRENDAHL J, LEVINE H: Intravenous and intrathecal miconazole therapy for systemic mycoses. West. J. Med. (1977) 126(1):5-13.
146. SUNG J, CAMPBELL G, GRENDAHL J: Miconazole therapy for fungal meningitis. Arch. Neurol. (1978) 35(7):443-447.
147. MORISON A, ERASMUS D, BOWIE M: Treatment of Candida albicans meningitis with intravenous and intrathecal miconazole. A case report. S. Afr. Med. J. (1988) 74(5):235-236.
148. SHEHAB Z, BRITTON H, DUNN J: Imidazole therapy of coccidioidal meningitis in children. Pediatr. Infect. Dis. J. (1988) 7(1):40-44.
149. HARRISON H, GALGIANI J, REYNOLDS AJ, SPRUNGER L, FRIEDMAN A. Amphotericin B and imidazole therapy for coccidioidal meningitis in children. Pediatr. Infect. Dis. (1983) 2(3):216-221.
150. AIDEM HP: Intra-articular amphotericin B in the treatment of coccidioidal synovitis of the knee. Case report. J. Bone Joint Surg. Am. (1968) 50(8):1663-1668.
151. KLEIN J, YAMAUCHI T, HORLICK S: Neonatal candidiasis, meningitis and arthritis: observations and a review of the literature. J. Pediatr. (1972) 81(1):31-34.
152. GREENMAN R, BECKER J, CAMPBELL G, REMINGTON J: Coccidioidal synovitis of the knee. Arch. Intern. Med. (1975) 135(4):526-530.
153. WINTER WG Jr, LARSON RK, HONEGGAR MM, JACOBSEN DT, PAPPAGIANIS D, HUNTINGTON RW Jr: Coccidioidal arthritis and its treatment. J. Bone Joint Surg. Am. (1975) 57(8):1152-1157.
154. BAYER A, GUZE L: Fungal arthritis. II. Coccidioidal synovitis: clinical, diagnostic, therapeutic and prognostic considerations. Semin. Arthritis Rheum. (1979) 8(3):200-211.
155. PRUITT AW, ACHORD JL, FALES FW, PATTERSON JH: Glucose-galactose malabsorption complicated by monilial arthritis. Pediatrics (1969) 43(1):106-110.
156. GULLBERG R, QUINTANILLA A. LEVIN M, WILLIAMS J, PHAIR J: Sporotrichosis: recurrent cutaneous, articular and central nervous system infection in a renal transplant recipient. Rev. Infect. Dis. (1987) 9(2):369-375.
157. LACHMAN RS, YAMAUCHI T, KLEIN J: Neonatal systemic candidiasis and arthritis. Radiology (1972) 105(3):631-632.
158. POPLACK DG, JACOBS SA: Candida arthritis treated with amphotericin B. J. Pediatr. (1975) 87(6 Pt 1):989-990.
159. BREWER TE, CALDWELL FT, PATTERSON RM, FLANIGAN WJ: Indwelling peritoneal (tenckhoff) dialysis catheter. Experience with 24 patients. JAMA (1972) 219(8):1011-1015.
160. BORTOLUSSI RA, MacDONALD MR, BANNATYNE RM, ARBUS GS: Treatment of Candida peritonitis by peritoneal lavage with Amphotericin B. J. Pediatr. (1975) 87(6 Pt 1):987-988.
161. BAYER AS, BLUMENKRANTZ MJ, MONTGOMERIE JZ, GALPIN JE, COBURN JW, GUZE LB: Candida peritonitis. Report of 22 cases and review of the English language. Am. J. Med. (1976) 61(6):832-840.
162. ARFANIA D, EVERETT ED, NOLPH KD, RUBIN J: Uncommon causes of peritonitis in patients undergoing peritoneal dialysis. Arch. Intern. Med. (1981) 141(1):61-64.
163. HOLDSWORTH SR, ATKINS RC, SCOTT DF, JACKSON R. Management of Candida peritonitis by prolonged peritoneal lavage containing 5-Fluorocytosine. Clin. Nephrol (1975) 4(4):157-159.
164. PHILLIPS I, EYKYN S, MacGREGOR G, JONES N: Candida peritonitis treated with 5-fluorocytosine in a patient receiving hemodialysis. Clin. Nephrol. (1973) 1(4):271-272.
165. THEODORE FH, LITTMAN ML, ALMEDO E: The diagnosis and management of fungus endophthalmitis following cataract extraction. Arch. Ophthalmol. (1962) 66:39-51.
166. MOSIER MA, LUSK B, PETTIT TH, HOWARD DH, RHODES J: Fungal endophthalmitis following intraocular lens implantation. Am. J. Ophthalmol. (1977) 83(1):1-8.
167. O'DAY D: Selection of appropriate antifungal therapy. Cornea (1987) 6(4):238-245.
168. DUKE UNIVERSITY MEDICAL CENTER IV PHARMACY: (Personal Communication). Dose/concentration of amphotericin B for intraviteral administration. (Nov. 26, 2003)
169. BHOMAJ S, DAS J, CHAUDHURI Z, BANSAL R, SHARMA P: Rhinosporidiosis and peripheral keratitis. Ophthalmic Surg. Lasers (2001) 32(4):338-340.
170. LOTERY AJ, KERR JR, PAGE BA. Fungal keratitis caused by Scopulariopsis brevicaulis: Successful treatment with topical amphotericin B and chloramphenicol without the need for surgical debridement. Br. J. Ophthalmol. (1994) 78:730
171. WOOD TO, WILLIFORD W: Treatment of keratomycosis with amphotericin B 0.15%. Am. J. Ophthalmol. (1976) 81(6):847-849.
172. WOOD TO, TUBERVILLE AW: Keratomycosis and amphotericin B. Trans. Am. Ophth. Soc. (1985) 83:397-409.
173. JONES DB, SEXTON R, REBELL G: Mycotic keratitis in south Florida: A review of thirty-nine cases. Trans. Ophth. Soc. (1969) 89:781-797.
174. ANDERSON B, CHICK EW: Mycokeratitis: Treatment of fungal corneal ulcers with amphotericin B and mechanical debridement. South. Med. J. (1963) 56:270-274.
175. FOSTER CS. Miconazole therapy for keratomycosis. Am. J. Ophthalmol (1981) 91:622-629.
176. SPONSEL W, GRAYBILL J, NEVAREZ H, DANG D: Ocular and systemic posaconazole(SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis. Br. J. Ophthalmol. (2002) 86(7):829-830.
177. JONES BR: Jackson memorial lecture. Am. J. Ophthalmol. (1975) 79(5):719-751.
178. GREEN WR, BENNETT J, GOOS RD: Ocular penetration of amphotericin B. Arch. Ophthalmol. (1965) 73:769-775.
179. KERMANI NK, AGGARWAL SP: Isolated post-operative Aspergillus niger endophthalmitis. Eye (2000) 14(1):114-116.
180. PETTIT T, OLSEN R, FOOS R, MARTIN W: Fungal endophthalmitis following intraocular lens implantation: A surgical epidemic. Arch. Ophthalmol. (1980) 98:1025-1039.
181. MASON J 3rd, PARKER J: Subconjunctival miconazole and anterior segment blastomycosis. Am. J. Ophthalmol. (1993) 116(4):506-507.
182. RITTERBAND DC, SHAH M, SEEDOR J: Colletotrichum graninicola: A new corneal pathogen. Cornea (1997) 16(3):362-364.
183. KURIAKOSE T, KOTHARI M, PAUL P, JACOB P, THOMAS R. Intracameral amphotericin B injection in the management of deep keratomycosis. Cornea (2002) 21(7):653-656.
184. KAUSHIK S, RAM J, BRAR G, JAIN A, CHAKRABORTI A, GUPTA A. Intracameral amphotericin B: initial experience in severe keratomycosis. Cornea (2001) 20(7):715-719.
185. HIROSE H, TERASAKI H, AWAYA S, YASUMA T: Treatment of fungal corneal ulcers with amphotericin B ointment. Am. J. Ophthalmol. (1997) 124(6):836-838.
186. JONES DB: Therapy of postsurgical fungal endophthalmitis. Ophthalmology (1978) 85:357-373.
187. ROSEN R, FRIEDMAN AH: Successfully treated postoperative Candida parakrusei endophthalmitis. Am. J. Ophthalmol. (1973) 76(4):574-577.
188. PFLUGFELDER S, FLYNN HJ, ZWICKEY T et al.: Exogenous fungal endophthalmitis. Ophthalmology (1988) 95:19-30.
189. SCOTT I, FLYNN HJ, MILLER D, SPEIGHTS J, SNIP R, BROD R. Exogenous endophthalmitis caused by amphotericin,B-resistant Paecilomyces lilacinus: treatment options and visual outcomes. Arch. Ophthalmol. (2001) 119(6):916-919.
190. CUTLER JE, BINDER PS, PAUL TO, BEAMIS JF: Metastatic coccidioidal endophthalmitis. Arch. Ophthalmol. (1978) 96:689-691.
191. WEISSGOLD D, ORLIN S, SULEWSKI M, FRAYER W, EAGLE RJ: Delayed-onset fungal keratitis after endophthalmitis. Ophthalmology (1998) 105(2):258-262.
192. WEISSGOLD D, MAGUIRE AM, BRUCKER AJ: Management of postoperative Acremonium endophthalmitis. Ophthalmology (1996) 103(5):749-756.
193. BROD R, FLYNN H Jr., CLARKSON JG, PFLUGFELDER S, CULBERTSON WW, MILLER D: Endogenous Candida endophthalmitis. Ophthalmology (1990) 97(5):666-674.
194. BORNE M, ELLIOTT J, O'DAY D: Ocular fluconazole treatment of Candida parapsilosis endophthalmitis after failed intravitreal amphotericin B. Arch. Ophthalmol. (1993) 111(10):1326-1327.
195. GOODMAN D, STERN W. Oral ketoconazole and intraocular amphotericin B for treatment of postoperative Candida parapsilosis endophthalmitis. Arch. Ophthalmol. (1987) 105(2):172-173.
196. STERN W. TAMURA E, JACOBS R, PONS V. STONE R, O'DAY D, IRVINE A: Epidemic postsurgical Candida parapsilosis endophthalmitis. Clinical findings and management of 15 consecutive cases. Ophthalmology (1985) 92(12):1701-1709.
197. GILBERT CM, NOVAK MA: Successful treatment of postoperative Candida endophthalmitis in an eye with an intraocular lens implant. Am. J Ophthalmol. (1984) 97:593-595.
198. HOGEWEG M, DE JONG PTVM: Candida endophthalmitis in heroin addicts. Doc. Ophthalmol. (1983) 55:63-71.
199. STRANSKY TJ: Postoperative endophthalmitis secondary to Candida Parapsilosis. Retina (1981) 1(3):179-183.
200. CAHILL K, HOGAN C, KOLETAR S, GERSMAN M: Intraorbital injection of amphotericin B for palliative treatment of Aspergillus orbital abscess. Ophthal. Plast. Reconstr. Surg. (1994) 10(4):276-277.
201. GOLDBLUM D, FRUEH B, ZIMMERLI S, BOHNKE M: Treatment of postkeratitis Fusarium endophthalmitis with amphotericin B lipid complex. Cornea (2000) 19(6):853-856.
202. LUNA J, PONSSA X, RODRIGUEZ S, LUNA N, JUAREZ C: Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis. Ophthalmic Surg. Lasers (1996) 27(8):706-708.
203. LEWIS RE, KONTOYIANNIS DP DAROUICHE RO, RAAD II, PRINCE RA. Antifungal activity of amphotericin B, fluconazole and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob. Agents Chemother. (2002) 46(11):3499-3505.
204. BENOIT J, CARANDANG G, SITRIN M, ARNOW P: Intraluminal antibiotic treatment of central venous catheter infections in patients
205. ARNOW PM, KUSHNER R: Malassezia further catheter infection cured with antibiotic lock therapy. Am. J. Med. (1991) 90(1):128-130.
206. MERMEL LA, FARR BM, SHERERTZ RJ et al.: Management of intravascular catheter-related infections. Clin. Infect. Dis. (2001) 32:1249-1272.
207. LAUBENHEIMER R: Oral amphotericin B in North American Blastmycosis. Arch. Dermatol. (1964) 89:832-836.
208. DUNN YO, McMILLEN S, CORNBLEET T: Oral amphotericin B therapy in Blastomycosis Arch. Dermatol. (1963) 88:127-129.
209. EPSTEIN JB, POLSKY B: Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies. Clin. Ther. (1998) 20(1):40-57.
210. MONTES L, COOPER M, BRADFORD L, LAUDERDALE R, TAYLOR C: Prolonged oral treatment of chronic mucocutaneous candidiasis with Amphotericin B. Arch. Dermatol (1971) 104(1):45-56.
211. MONTES L, MOORE WJ, SOTO TG, MAZZINI MA: Amphotericin B tablets in oral candidiasis. Cutis (1973) 11:146-148.
212. EZDINLI E, O'SULLIVAN D, WASSER L, KIM U, STUTZMAN L: Oral amphotericin for candidiasis in patients with hematologic neoplasms. An autopsy study. JAMA (1979) 242(3):258-260.
213. BISSELL V, FELIX DH, WRAY D: Comparative trial of fluconazole and amphotericin in the treatment of denture stomatitis. Oral Surg. Oral Med. Oral Pathol. (1993) 76(1):35-39.
214. FUKUSHIMA C, SHIMODA T, KAWANO T et al.: Effects of amphotericin B gargles on oral colonization of Candida albicans in asthmatic patients on steroid inhalation therapy. Respiration (2001) 68(5):465-470.
215. NAKAZAWA I, OUCHI E, OUCHI K, WAGAI K: The effect of oral administration of amphotericin B on the incorporation of 5-Fluorouracil into human gastric cancer tissues. Tohoku J. Exp. Med. (1980) 133(3):361-362.
216. GRIM S, SMITH K, ROMANELLI F, OFOTOKUN I: Treatment of azole-resistant oropharyngeal candidiasis with topical amphotericin B. Ann Pharmacother. (2002) 36(9):1383-1386.
217. ALBAN J, GROEL JT. Amphotericin B oral suspension in the treatment of thrush. Curr Ther. Res. (1970) 12(8):479-484.
218. FICHTENBAUM CJ, ZACKIN R, RAJICIC N, POWDERLY WG, WHEAT LJ, ZINGMAN BS: Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. AIDS (2000) 14:845-851.
219. BARRETT AP: A long-term prospective clinical study of oral complications during conventional chemotherapy for acute leukemia. Oral Surg. Oral Med. Oral Pathol. (1987) 63:313-316.
220. BODEY GP, RODRIGUEZ V: Infections in cancer patients on a protected enviornment-prophylactic antibiotic program. Am. J. Med. (1975) 59:497-504.
221. NGUYEN M, WEISS P, LABARRE R, MILLER L, OLDFIELD E, WALLACE M: Orally administered amphotericin B in the treatment of oral candidiasis in HIV-infected patients caused by azole-resistant Candida albicans. AIDS (1996) 10(14):1745-1747.
222. BRANDELL R, CHASE SL, COHN JR: Treatment of oral candidiasis with amphotericin B solution. Clin. Pharm. (1988) 7:70-72.
223. DEWSNUP DH, STEVENS D: Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole. J. Med. Vet. Mycol. (1994) 32:389-393.
224. FORTUN J, MARTIN-DAVILA P, DE VICENTE E et al.: Prophylaxis with oral fluconazole and an oral solution of amphotericin B in liver transplant patients. Transplant. Proc. (2002) 34(1):80-81.
225. HUANG NN, SARRIA, A, HIGH RH: Therapeutic evaluation of nystatin and amphotericin in oral moniliasis in infants and children. Antibiotics Annual (1958) 1957-1958:59-64.
226. LEFEBVRE J, DOMENGE C, STUDY GROUP OF MUCOSITIS: A comparative study of the efficacy and safety of fluconazole oral suspension and amphotericin B oral suspension in cancer patients with mucositis. Oral. Oncol. (2002) 38(4):337-342.
227. TAILLANDIER J, ESNAULT Y, ALEMANNI M: A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis. Multicentre Study Group. Age Ageing (2000) 29(2):117-123.
228. CHING M, RAYMOND K, BURY R, MASHFORD M, MORGAN D: Absorption of orally administered amphotericin B lozenges. Br. J. Clin. Pharmacol. (1983) 16(1):106-108.
229. VRIES-HOSPERS H, VAN DER WD: Salivary concentrations of amphotericin B following its use as an oral lozenge. Infection (1980) 8(2):63-65.
230. MENICHETTI F, DEL FAVERO A, MARTINO P et al.: Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B. The GIMEMA Infection Program. Ann. Intern. Med. (1994) 120(11):913-918.
231. PHILPOTT-HOWARD J, WADE J, MUFTI G, BRAMMER K, EHNINGER G: Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. J. Antimicrob. Chemother. (1993) 31(6):973-984.
232. ABBAS AA, FELIMBAN SK, YOUSEF AA, KHATTAB TM, FRYER CJ, NANDAGOPAL N: Aggressive cutaneous Aspergillus infection: control by local irrigation with amphotericin B. Med. Pediatr. Oncol. (2002) 39(2):139-140.
233. KLUGE RM, HORNICK RB: Sporotrichosis: An unusual desseminated cutaneous case and a fatal pulmonary case. South. Med. J. (1976) 69(7):855-857.
234. SILVERBERG D, KODALI P, DIPERSIO J, ACUS R, ASKEW M: In vitro analysis of antifungal impregnated polymethylmethacrylate bone cement. Clin. Orthop. (2002) 403:228-231.
235. SELMON G, SLATER R, SHEPPERD J, WRIGHT E: Successful 1-stage exchange total knee arthroplasty for fungal infection. J. Arthroplasty (1998) 13(1):114-115.